European Union’s drug regulator said it has found a possible blood clot link with the Johnson & Johnson vaccine but stressed the benefits of the shot outweigh the risk, coming about a week after U.S. health regulators recommended a pause.
The European Medicines Agency (EMA) said its “safety committee concluded that a warning about unusual blood clots with low blood platelets should be added to the product information for COVID-19 Vaccine Janssen,” according to a statement published Tuesday.
